The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).
Lymphoma, Follicular
The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
-
Local Institution - 0152, Birmingham, Alabama, United States, 35294-3300
Alaska Oncology and Hematology, Anchorage, Alaska, United States, 99508
Mayo Clinic in Arizona - Phoenix, Phoenix, Arizona, United States, 85054
Local Institution - 0190, Tucson, Arizona, United States, 85711
Local Institution - 0035, San Francisco, California, United States, 94143
Local Institution - 0022, Washington, District of Columbia, United States, 20007
Local Institution - 0209, Fort Myers, Florida, United States, 33901
Mayo Clinic in Florida, Jacksonville, Florida, United States, 32224
Local Institution - 0210, Saint Petersburg, Florida, United States, 33705
Tampa General Hospital, Tampa, Florida, United States, 33606
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Celgene,
Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb
2028-11-27